Hugo A. Barrera-Saldaña, Innbiogem, SC, Laboratorio Nacional Biobanco, Monterrey, Nuevo León, México; Facultades de Medicina y Ciencias Biológicas, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México;
Alfredo Ulloa-Aguirre, Red de Apoyo a la Investigación, Universidad Nacional Autónoma de México, Ciudad de México, México; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
Juan P. Reyes, Instituto Nacional de Medicina Genómica, Ciudad de México, México
Berenice Illiades, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, México
Sofía Bernal, Universidad Autónoma de San Luis Potosí, San Luis Potosí, San Luis Potosí, México
Celia Alpuche, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México
Claudia M. Luna, Vitagénesis, SA de CV, Monterrey, Nuevo León, México
Karen Moreno, Vitagénesis, SA de CV, Monterrey, Nuevo León, México
Karla Estrada, Vitagénesis, SA de CV, Monterrey, Nuevo León, México
Martín Lajous, Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Ciudad de México, México; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, Estados Unidos de América
Ruy López-Ridaura, Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Ciudad de México, México
Miguel A. Campomanes, Innbiogem, SC, Laboratorio Nacional Biobanco, Monterrey, Nuevo León, México
The development of biobanks in Mexico has emerged as an essential strategic initiative to advance scientific research and its translation, to improve public health. This paper highlights the role of biospecimens, including surgical and liquid biopsies, in promoting diagnostic and therapeutic innovations. It underscores the importance of high-quality biobanking for translational research and the challenges faced due to insufficient infrastructure and professionalized services in Mexico. Through a historical overview, the paper describes the origin and initial evolution of biobanking efforts in Mexico, from establishing the first institutional biobanks to creating the National Biobank Laboratory (LANBIOBAN) network. The collaboration between national and international entities has allowed Mexico to engage in global biobanking networks, furthering precision medicine. Despite limited resources, these biobanks are fostering significant progress in translational research, improving diagnostic and therapeutic practices, and bridging the gap between research and clinical application.
Keywords: Biobanks. Translational research. Biospecimens. Precision medicine. Mexican health.